The assessment of angiogenesis and fibroblastic stromagenesis in hyperplastic and pre-invasive breast lesions
The assessment of angiogenesis and fibroblastic stromagenesis in hyperplastic and pre-invasive breast lesions
复制标题
DOI:
10.1186/1471-2407-8-88
复制
发表时间:
2008-04-02
期刊:
影响因子:
3.8
通讯作者:
Stathopoulos, Efstathios N.
中科院分区:
文献类型:
--
作者:
Pavlakis, Kitty;Messini, Irene;Stathopoulos, Efstathios N.
Background: To investigate the changes of the neoplastic microenvironment during the different morphological alterations of hyperplastic and pre-invasive breast lesions.Methods: 78 in situ ductal carcinomas of all degrees of differentiation, 22 atypical ductal hyperplasias, 25 in situ lobular carcinomas, 18 atypical lobular hyperplasias, 32 ductal epithelial hyperplasias of usual type and 8 flat atypias were immunohistochemically investigated for the expression of vascular endothelial growth factor ( VEGF), smooth muscle actin ( SMA) and CD34, while microvessel density ( MVD) was counted using the anti-CD31 antibody.Results: VEGF expression was strongly correlated with MVD in all hyperplastic and pre-invasive breast lesions ( p < 0.05). Stromagenesis, as characterized by an increase in SMA and a decrease in CD34 positive myofibroblasts was observed mostly around ducts harboring high grade in situ carcinoma and to a lesser extent around moderately differentiated DCIS. In these two groups of in situ carcinomas, a positive correlation between MVD and SMA ( p < 0.05) was observed. On the contrary, CD34 was found to be inversely related to MVD ( p < 0.05). No statistically significant changes of the stromal fibroblasts were observed in low grade DCIS neither in any of the other lesions under investigation as compared to normal mammary intra- and interlobular stroma.Conclusion: Angiogenesis is observed before any significant fibroblastic stromagenesis in pre-invasive breast lesions. A composite phenotype characterized by VEGF positive epithelial cells and SMA positive/CD34 negative stromal cells, is identified mostly in intermediate and high grade DCIS. These findings might imply for new therapeutic strategies using both anti- angiogenic factors and factors selectively targeting tumor stroma in order to prevent the progression of DCIS to invasive carcinoma.